Biomarkers of Metabolic Syndrome: Role in Pathogenesis and Pathophysiology Of Atrial Fibrillation
- PMID: 34950373
- PMCID: PMC8691267
- DOI: 10.4022/jafib.20200495
Biomarkers of Metabolic Syndrome: Role in Pathogenesis and Pathophysiology Of Atrial Fibrillation
Abstract
The relationship between Metabolic syndrome and Atrial Fibrillation is confirmed by many studies. The components of Metabolic syndrome cause remodeling of the atrial. Metabolic syndrome and metabolic derangements of the syndrome could be the cause of the pathogenesis of AF. This review article discusses the major biomarkers of Metabolic syndrome and their role in the pathogenesis of AF. The biomarkers are adiponectin, leptin, Leptin/ Adiponectin ratio, TNF-α, Interleukin-6, Interleukin-10, PTX3, ghrelin, uric acid, and OxLDL.The elevated plasma levels of adiponectin were linked to the presence of persistent AF. Leptin signaling contributes to angiotensin-II evoked AF and atrial fibrosis. Tumor necrosis factor-alpha involvement has been shown in the pathogenesis of chronic AF. Similarly, Valvular AF patients showed high levels of TNF-α. Increased left atrial size was associated with the interleukin-6 because it is a well-known risk factor for AF. Interleukin-10 as well as TNF-α were linked to AF recurrence after catheter ablation. PTX3 could be superior to other inflammatory markers that were reported to be elevated in AF. The serum ghrelin concentration in AF patients was reduced and significantly increased after treatment. Elevated levels of uric acid could be related to the burden of AF. Increased OxLDL was found in AF as compared to sinus rhythm control.
Keywords: Adiponectin; Atrial fibrillation; Ghrelin; Interleukin -10; Interleukin- 6; Leptin; Metabolic syndrome; OxLDL; Tumor necrosis factor-alpha; Uric acid.
Figures
Similar articles
-
Elevated Circulating Fibrocytes Is a Marker of Left Atrial Fibrosis and Recurrence of Persistent Atrial Fibrillation.J Am Heart Assoc. 2018 Mar 13;7(6):e008083. doi: 10.1161/JAHA.117.008083. J Am Heart Assoc. 2018. PMID: 29535140 Free PMC article.
-
Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability.J Cell Mol Med. 2020 Jul;24(14):7751-7766. doi: 10.1111/jcmm.15407. Epub 2020 May 22. J Cell Mol Med. 2020. PMID: 32441464 Free PMC article.
-
Serum levels of interleukin-2 predict the recurrence of atrial fibrillation after pulmonary vein ablation.Cytokine. 2015 May;73(1):74-8. doi: 10.1016/j.cyto.2015.01.026. Epub 2015 Mar 2. Cytokine. 2015. PMID: 25743240
-
Biomarkers of diabetes: role in the pathogenesis of atrial fibrillation.Eur Rev Med Pharmacol Sci. 2024 Feb;28(4):1524-1540. doi: 10.26355/eurrev_202402_35482. Eur Rev Med Pharmacol Sci. 2024. PMID: 38436186 Review.
-
Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Ann Med. 2015 Jun;47(4):316-24. doi: 10.3109/07853890.2015.1042030. Epub 2015 May 18. Ann Med. 2015. PMID: 25982799 Review.
Cited by
-
Biomarkers and Seaweed-Based Nutritional Interventions in Metabolic Syndrome: A Comprehensive Review.Mar Drugs. 2024 Dec 4;22(12):550. doi: 10.3390/md22120550. Mar Drugs. 2024. PMID: 39728125 Free PMC article. Review.
-
Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders.J Pers Med. 2023 Aug 28;13(9):1323. doi: 10.3390/jpm13091323. J Pers Med. 2023. PMID: 37763092 Free PMC article. Review.
-
Cardiovascular adaptations and inflammation in marathon runners.Exp Ther Med. 2022 Sep 29;24(5):699. doi: 10.3892/etm.2022.11635. eCollection 2022 Nov. Exp Ther Med. 2022. PMID: 36277142 Free PMC article.
-
Integrative multi-omics summary-based mendelian randomization identifies key oxidative stress-related genes as therapeutic targets for atrial fibrillation and flutter.Front Genet. 2024 Sep 18;15:1447872. doi: 10.3389/fgene.2024.1447872. eCollection 2024. Front Genet. 2024. PMID: 39359474 Free PMC article.
-
Machine Learning-Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals.JMIRx Med. 2024 Sep 11;5:e56993. doi: 10.2196/56993. JMIRx Med. 2024. PMID: 39263921 Free PMC article.
References
-
- Ford JD, Ford LW, D'Amelio A. Resistance to change: The rest of the story. Academy of Management Review. 2008;0:362–377.
-
- Kannel W B, Wolf P A, Benjamin E J, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998 Oct 16;82 (8A):2N–9N. - PubMed
-
- Kunneman Marleen, Branda Megan E, Hargraves Ian G, Sivly Angela L, Lee Alexander T, Gorr Haeshik, Burnett Bruce, Suzuki Takeki, Jackson Elizabeth A, Hess Erik, Linzer Mark, Brand-McCarthy Sarah R, Brito Juan P, Noseworthy Peter A, Montori Victor M. Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation: A Randomized Clinical Trial. JAMA Intern Med. 2020 Sep 01;180 (9):1215–1224. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous